Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Daily News

Year in Review: Evidence Around AI in Cardiology Grows

Todd Neale

December 23, 2025

News Daily News

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Todd Neale

December 05, 2025

News Daily News

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Michael O'Riordan

June 24, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

L.A. McKeown

October 10, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Daily News

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Shelley Wood

July 20, 2021

News Daily News

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

Shelley Wood

June 24, 2021

News Daily News

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

Todd Neale

May 24, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Daily News

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

Michael O'Riordan

March 15, 2017

CME

Advertisement

Year in Review: Evidence Around AI in Cardiology Grows

FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF

Vutrisiran, an siRNA for ATTR-CM, Meets Primary Endpoint in HELIOS-B

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Debating the Role of T-TEER in the Sickest Patients

TCTMD’s Top 10 Most Popular Stories for February 2024

FDA Panel Takes a Positive View of TriClip in Tricuspid Regurgitation

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Decides Not to Approve Patisiran in ATTR Cardiomyopathy

TCTMD’s Top 10 Most Popular Stories for August 2023

August 2023 News Roundup

Top Heart Failure News of 2022

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

June 2022 News Roundup

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

CDC Says Myocarditis ‘Likely’ Linked to mRNA Vaccines but Very Rare

US, European Agencies Looking Into Myocarditis Reports Tied to mRNA COVID-19 Vaccines

Roughly 80% of ESC Guideline Writers Have Financial COIs

Fish Oils: Yes for HF and Secondary Prevention, No for the General Population, Says AHA

The Role of Atrial Shunts in the Treatment of HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content